Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Milliman estimates that a payer with high discontinuation rates may experience a 26% inefficiency in drug spend
are taking a GLP-1 receptor agonist medication to either lose weight or treat a chronic condition, and the adoption rate is only accelerating
It really turned me off
For patients on tirzepatide, which produces a more pronounced caloric deficit due to its dual GIP/GLP-1 mechanism, methylated B12 provides upgraded energy and cognitive support during the weight loss phase
BPC-157 Before and After for Gut Health: A Different Timeline Entirely Gut indications follow a fundamentally different before and after trajectory than musculoskeletal indications, and patients who come to Perfect B with both gut and injury concerns are often surprised by how much faster the gut improvements arrive
Sophie believes that patients make better decisions when they have access to accurate, evidence-based information
